Denmark Medical only

Legal Framework

Recreational cannabis use, possession, and sale remain fully illegal in Denmark. Cannabis is listed as a List A substance under the Danish Act on Euphoriant Substances, the same formal control category as heroin and LSD, though in practice enforcement for personal-use amounts is handled through fines rather than criminal prosecution. Possession of a small personal quantity (roughly under 10 grams) typically results in a fixed fine, commonly cited around 2,000 DKK for a first offence, rising for repeat offences; the statutory maximum for simple possession is up to 2 years' imprisonment, and supply or larger quantities can carry up to 10 years under the Penal Code. There is no formal decriminalization law, though several parties in the Folketing have voiced support for one (LegalClarity).

Copenhagen's Christiania freetown was long known for its semi-tolerated open-air cannabis market on "Pusher Street." That market was dismantled by authorities in 2024 following gang-related violence, so travelers should not expect Christiania to function as a safe or quasi-legal place to buy cannabis in 2025/2026 — buying or possessing cannabis anywhere in Denmark, including Christiania, remains illegal and enforced (Herb).

Denmark also applies a strict zero-tolerance drug-driving standard: any detectable THC above a very low threshold (around 0.003 mg per kg of blood) triggers a fine and typically a multi-year driving ban, regardless of impairment (Sensi Seeds). It is unconfirmed whether this applies identically to patients using legally prescribed medical cannabis — the Danish Patient Safety Authority was tasked in 2025 with revising driving-related health guidance for medical cannabis patients, but no finalized separate standard for prescribed patients has been confirmed in available sources.

Medical Cannabis Program

Denmark ran a medical cannabis pilot scheme ("forsøgsordning") from 2018 to 2025. On 24 April 2025, the Danish Parliament (Folketing) passed Bill L135, converting the pilot into permanent law effective 1 January 2026 (Inderes). Under the permanent framework, any Danish doctor — not only specialists — can prescribe medical cannabis to any patient for any condition where they judge the treatment clinically appropriate, making Denmark's system one of the broadest physician-discretion models in Europe.

Available products include registered pharmaceuticals such as Sativex and Epidyolex, prescribed by specialists under normal drug rules, alongside a wider range of cannabis flower, oil, and extract products supplied by licensed producers under the pilot/magistral routes, including domestic manufacturers like STENOCARE. A 50% public subsidy on the cost of prescribed medical cannabis products continues under the new law, though patient advocates and industry voices have criticized the remaining out-of-pocket cost as still high relative to conventional medicines (Business of Cannabis).

For residents, the process is straightforward in principle: discuss the treatment option with a GP or specialist, receive a prescription if judged appropriate, and fill it at a pharmacy. The system, however, is built around established Danish patients with an ongoing doctor relationship, not around visitors.

Traveling with Medical Cannabis

Travelers who already hold a legitimate prescription for medical cannabis in their home country may bring it into Denmark for personal use, generally understood to cover a supply of around 30 days, provided the medication is accompanied by:

• The original, named prescription in the patient's name
• A completed Schengen Article 75 certificate (sometimes called a "pill pass") obtained from a pharmacy or competent authority in the home country before departure
• Ideally, original packaging and a doctor's letter describing the condition and dosage

Because the certificate is issued under the Schengen Implementing Convention, it is designed for travel between Schengen states carrying a controlled medicine already lawfully prescribed elsewhere — it does not create a new prescription in Denmark. Visitors cannot simply arrive and ask a Danish doctor for a first-time medical cannabis prescription the way an established resident patient can; the system assumes an ongoing clinical relationship. Anyone planning to bring medical cannabis into Denmark should confirm requirements with the Danish Medicines Agency (Lægemiddelstyrelsen) and their home pharmacy well before travel, since exact border documentation checks are not centrally published in detail.

Recent Developments

• April 2025: Folketing passes Bill L135, ending the pilot-scheme status of medical cannabis.
• 1 January 2026: Permanent medical cannabis law takes effect; prescribing opens to all doctors for all conditions at clinical discretion.
• 2024: Christiania's "Pusher Street" open cannabis market dismantled by authorities.
• Ongoing: Danish Patient Safety Authority reviewing driving-related health guidance for medical cannabis patients; patient groups continue to flag the remaining co-payment as a barrier despite the 50% subsidy.

Frequently Asked Questions

Can I bring my prescribed medical cannabis into Denmark as a tourist?
Yes, in principle, if you carry a valid Schengen Article 75 certificate matching your home-country prescription, generally limited to roughly a 30-day personal supply.

Can I get a new Danish medical cannabis prescription while visiting?
Not realistically. The system is built for established Danish patients with an ongoing doctor relationship, not for short-term visitors seeking a first prescription.

Is Christiania still a place where cannabis is effectively tolerated?
No. The open "Pusher Street" market was dismantled in 2024, and cannabis possession and sale remain illegal and enforced throughout Denmark, including Christiania.

Does a prescription protect me from Denmark's zero-tolerance drug-driving law?
This is unconfirmed. Denmark's THC driving threshold is extremely low, and while authorities are reviewing rules specific to medical cannabis patients, no confirmed separate standard exists yet in available sources — treat driving after use as high risk regardless of prescription status.